Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | NovoSeven® RT (coagulation Factor VIIa, |
Description | Experience where it NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medication used to treat bleeding in hemophilia A or B with inhibitors, congenital FVII deficiency, and Glanzmann’s thrombasthenia when platelets don’t work, and adults with |
Keywords | N/A |
WebSite | novosevenrt.com |
Host IP | 72.3.137.119 |
Location | United States |
Site | Rank |
US$17,459,134
Last updated: 2023-05-16 05:27:19
novosevenrt.com has Semrush global rank of 606,233. novosevenrt.com has an estimated worth of US$ 17,459,134, based on its estimated Ads revenue. novosevenrt.com receives approximately 2,014,516 unique visitors each day. Its web server is located in United States, with IP address 72.3.137.119. According to SiteAdvisor, novosevenrt.com is safe to visit. |
Purchase/Sale Value | US$17,459,134 |
Daily Ads Revenue | US$16,117 |
Monthly Ads Revenue | US$483,484 |
Yearly Ads Revenue | US$5,801,805 |
Daily Unique Visitors | 134,302 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
novosevenrt.com. | A | 299 | IP: 72.3.137.119 |
novosevenrt.com. | NS | 21600 | NS Record: ns.rackspace.com. |
novosevenrt.com. | NS | 21600 | NS Record: ns2.rackspace.com. |
novosevenrt.com. | TXT | 300 | TXT Record: google-site-verification=gHkGK69EvGdAAEyTwL2yp7VB2hyFgnBGvZIyJ2_8PL8 |
novosevenrt.com. | TXT | 300 | TXT Record: mcrh6wc6klld9hwfmr7v11scpcclrmt5 |
Prescribing Information Important Safety Information For Health Care Professionals About Novo Nordisk NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) Home Why NovoSeven ® RT Benefits Considering Treatment Community Stories What Does It Treat? Hemophilia A with Inhibitors Hemophilia B with Inhibitors Factor VII Deficiency Glanzmann’s Thrombasthenia When Platelets Don’t Work Acquired Hemophilia Identifying Bleeds Safety Profile Starting Treatment Getting Your Factor Preparing for an Infusion Performing an Infusion Getting Support How We Can Help At a Glance Product Support Education for You Contact Us Experience where it matters. For more than 30 years, healthcare providers and people with rare bleeding disorders a have trusted NovoSeven ® RT. It’s the first and only recombinant factor VIIa (rFVIIa) that is: Indicated for people of all ages with hemophilia A or B with inhibitors, congenital FVII deficiency, and Glanzmann’s thrombasthenia when platelets don’t work, and adults with |
HTTP/1.1 301 Moved Permanently Date: Wed, 19 Jan 2022 09:53:38 GMT Server: Apache/2.4.43 (IUS) OpenSSL/1.0.2k-fips Communique/4.3.2 Location: https://www.novosevenrt.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 date: Wed, 19 Jan 2022 09:53:39 GMT server: Apache/2.4.43 (IUS) OpenSSL/1.0.2k-fips Communique/4.3.2 last-modified: Tue, 18 Jan 2022 21:31:34 GMT etag: "134bf-5d5e1fe562cd2" accept-ranges: bytes content-length: 79039 vary: Accept-Encoding content-disposition: inline content-type: text/html; charset=UTF-8 |
Domain Name: NOVOSEVENRT.COM Registry Domain ID: 1403164305_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.dynadot.com Registrar URL: http://www.dynadot.com Updated Date: 2022-01-18T21:27:46Z Creation Date: 2008-02-15T01:59:25Z Registry Expiry Date: 2024-02-15T01:59:25Z Registrar: DYNADOT, LLC Registrar IANA ID: 472 Registrar Abuse Contact Email: abuse@dynadot.com Registrar Abuse Contact Phone: +16502620100 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS.RACKSPACE.COM Name Server: NS2.RACKSPACE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-01-19T07:33:31Z <<< |